{
    "2019-08-23": [
        [
            {
                "time": "",
                "original_text": "贪婪的药明康德",
                "features": {
                    "keywords": [
                        "药明康德",
                        "贪婪"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "价值+成长！182份三季报预告揭秘A股业绩“牛”",
                "features": {
                    "keywords": [
                        "三季报",
                        "A股",
                        "业绩",
                        "价值",
                        "成长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：上半年净利增逾6成，但财报却透露了几点瑕疵",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "净利",
                        "增长",
                        "财报",
                        "瑕疵"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)拟回购注销6.85万股 回购价格26.55元/股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "回购",
                        "注销",
                        "股价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【泰格医药】19年中报：订单饱满，全球化布局持续推进",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "中报",
                        "订单",
                        "全球化",
                        "布局"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药:乘行业东风,主业维持高增长",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "行业",
                        "东风",
                        "主业",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}